Malaria The Main Focus Of New GHIT Fund Allocations
This article was originally published in PharmAsia News
Executive Summary
Japan's GHIT Fund is making new investments in a slew of pipeline projects for malaria, tuberculosis, leishmaniasis and dengue that involve local pharma industry and other academic partners.